<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "thiotepa inj VIAL">
<dose><value>60</value>
</dose>
<route><value>INTRAVESICALLY</value>
</route>
<strength><value>15 mg</value>
</strength>
<frequency><value>WEEKLY</value>
</frequency>
<instruction><value>for 4 weeks. Retain solution for 2 hours.</value>
</instruction>
<volume></volume>
<units><value>mg</value>
</units>
<Population><value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Bladder Cancer. Dilute dose in 30 to 60 mL 0.9% sodium chloride.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3340</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary, Health Canada Special Access Programme.</value>
</AHSFormularyStatus>
<AHFSName><value>Antineoplastic Agents</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>